In the USA, The University of Kentucky is moving forward and working hard on a clinical trial proving the efficacy of Povidone-Iodine as a nasal spray in combating COVID. Meanwhile, some of the world’s most prestigious academic and medical establishments are doing shorter term studies and tipping their hat to those in the know...
“Just as we currently are used to regularly disinfecting our hands, in the future we may also make a habit of disinfecting our noses.”
Professor Friedland of the University of Western Australia.
Visit the full article here where researchers are sharing some information on the study being done on a Povidone-Iodine nasal spray…
NOTE:
The Australian study is based on a .05% solution. CofixRX uses a 1.5% solution and is available in the USA (retailers near you), Australia and Canada (online until we land a local distributor).